昊海生科(688366.SH)發行價確定為89.23元/股 10月21日申購
格隆匯10月17日丨昊海生科(688366.SH)發佈首次公開發行股票並在科創板上市發行公告,擬發行不超過1780萬股,發行價確定為89.23元/股。
依據發行人與保薦機構(主承銷商)協商確定的發行價格89.23元/股,此次發行規模超過人民幣10億元但不足人民幣20億元,根據《業務指引》規定,此次發行保薦機構相關公司跟投比例為4%,但不超過人民幣6000萬元。此次發行最終戰略配售數量為245.2419萬股,約佔發行總數量的13.78%,初始戰略配售股數與最終戰略配售股數的差額39,581股將回撥至網下發行。
此次網下發行申購日與網上申購日同為2019年10月21日(T日),其中,網下申購時間為9:30-15:00,網上申購時間為9:30-11:30,13:00-15:00,任一配售對象只能選擇網下發行或者網上發行一種方式進行申購。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.